Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour
IAMSAFE
1 other identifier
interventional
330
1 country
4
Brief Summary
Suicide is the leading cause of death due to illness among Canadian youth, claiming more lives than any medical illness, including cancer. Suicide prevention is possible, and early intervention is needed. The investigators will examine the effectiveness of a previously-piloted, ED-based suicide prevention intervention, across Canadian sites, using a randomized clinical trial design. The investigators will determine whether the patient- and family-centered intervention is more effective than enhanced usual care in reducing suicide-related behaviors in 330 youth at high-risk of suicide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 11, 2024
CompletedFirst Posted
Study publicly available on registry
January 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 18, 2025
September 1, 2025
4.8 years
January 11, 2024
September 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Suicide Risk Events (SREs) throughout 6 months of study engagement
Suicide attempts and unscheduled ED/hospital re-visits (including hospitalization) for SREs, or death by suicide during the 6-month follow up period. SREs will be determined by participant and caregiver report using validated questions regarding suicide attempts from the Columbia-Suicide Severity Rating Scale (C-SSRS).
Baseline, 6 weeks, 24 weeks
Secondary Outcomes (10)
Columbia-Suicide Severity Rating Scale (C-SSRS)
Baseline, 6 weeks, 24 weeks
Suicidal Ideation Questionnaire-Jr (SIQ-Jr)
Baseline, 6 weeks, 24 weeks
Schedule for Affective Disorders and Schizophrenia Depression Rating Scale (KSADS-DEPc)
Baseline, 6 weeks, 24 weeks
Screen for Child Anxiety Related Disorders (SCARED)
Baseline, 6 weeks, 24 weeks
Centre for Epidemiological Studies Depression Scale for Children (CES-DC)
Baseline, 6 weeks, 24 weeks
- +5 more secondary outcomes
Study Arms (2)
SAFE Intervention
EXPERIMENTALThis group will receive the SAFE individual youth and family-based intervention.
NAV (Telephone Navigation)
ACTIVE COMPARATORThis group will receive telephone-based case navigation.
Interventions
Manualized individual youth and family psychotherapeutic intervention. Weekly individual and family sessions with a therapist for 6 weeks. Participants will continue to receive usual care.
Weekly telephone contact with parents regarding participant health care utilization. Referrals to community mental health resources provided as needed. Participants will continue to receive usual care.
Eligibility Criteria
You may qualify if:
- Youth presenting in the Emergency Department with SIQ-Jr score ≥ 31,
- Has a participating parent or caregiver who is able to communicate easily in English, or is willing to communicate using a hospital-organized translator,
- Between the ages 12-17 years old,
- Living in the catchment area of one of the three hospital sites and access to a telephone.
You may not qualify if:
- Score of 3 on KSADS screen for current psychosis or elevated mood
- Moderate to severe intellectual disability, and/or autism based on clinical chart.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- Canadian Institutes of Health Research (CIHR)collaborator
- SickKids Foundationcollaborator
Study Sites (4)
Alberta Children's Hospital - Alberta Health Services & University of Calgary
Calgary, Alberta, T2W 1S7, Canada
McMaster Children's Hospital - Hamilton Health Sciences
Hamilton, Ontario, L8L 8E7, Canada
Trillium Health Partners
Mississauga, Ontario, L5B 1B8, Canada
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Study investigators and outcome assessors are blinded to allocation assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Scientist
Study Record Dates
First Submitted
January 11, 2024
First Posted
January 26, 2024
Study Start
March 1, 2021
Primary Completion
November 30, 2025
Study Completion
December 31, 2025
Last Updated
September 18, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share